In addition to its generous endowment, the Institute for Stem Cell Biology and Regenerative Medicine at Einstein is supported by external sources, including the NIH and the New York State Empire State Stem Cell (NYSTEM) Board. Created in 2007, NYSTEM provided substantial funding support for stem cell research over the next decade. Notably, Einstein is among the highest-ranked institutions in New York competing for state support and, to date, has received more stem cell funding from NYSTEM than any other institution.
Funding from NYSTEM supports the creation of the Einstein Comprehensive Pluripotent Stem Cell Center, which consists of three units: the Human Pluripotent Stem Cell Unit, the Cell-Sorting and Xenotransplantation Unit, and the Stem Cell Genomic Unit.
In addition, Einstein and its University Hospital, Montefiore Medical Center, have established consortia for blood cell disease and liver transplantation in New York State. The consortia aim to link research institutions and corporations, build and strengthen interdisciplinary research teams, establish core research facilities, and develop stem cell training and education programs. A not for- profit institution, Montefiore is one of the nation’s largest hospitals, with 1,491 beds.